Although TKIs, represented by third‐generation EGFR‐TKIs, have achieved remarkable success in the field of cancer treatment, clinical results show that there are still inevitable toxic side effects in the gastrointestinal tract, skin and other organs.232. The gene discussed is EGFR; the disease is cancer.